1. Home
  2. GNPX vs OLB Comparison

GNPX vs OLB Comparison

Compare GNPX & OLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNPX
  • OLB
  • Stock Information
  • Founded
  • GNPX 2009
  • OLB 1993
  • Country
  • GNPX United States
  • OLB United States
  • Employees
  • GNPX N/A
  • OLB N/A
  • Industry
  • GNPX Biotechnology: Pharmaceutical Preparations
  • OLB EDP Services
  • Sector
  • GNPX Health Care
  • OLB Technology
  • Exchange
  • GNPX Nasdaq
  • OLB Nasdaq
  • Market Cap
  • GNPX 5.5M
  • OLB 4.4M
  • IPO Year
  • GNPX 2018
  • OLB N/A
  • Fundamental
  • Price
  • GNPX $0.31
  • OLB $1.28
  • Analyst Decision
  • GNPX
  • OLB
  • Analyst Count
  • GNPX 0
  • OLB 0
  • Target Price
  • GNPX N/A
  • OLB N/A
  • AVG Volume (30 Days)
  • GNPX 23.7M
  • OLB 134.5K
  • Earning Date
  • GNPX 08-14-2025
  • OLB 08-19-2025
  • Dividend Yield
  • GNPX N/A
  • OLB N/A
  • EPS Growth
  • GNPX N/A
  • OLB N/A
  • EPS
  • GNPX N/A
  • OLB N/A
  • Revenue
  • GNPX N/A
  • OLB $10,410,379.00
  • Revenue This Year
  • GNPX N/A
  • OLB N/A
  • Revenue Next Year
  • GNPX N/A
  • OLB N/A
  • P/E Ratio
  • GNPX N/A
  • OLB N/A
  • Revenue Growth
  • GNPX N/A
  • OLB N/A
  • 52 Week Low
  • GNPX $0.14
  • OLB $0.95
  • 52 Week High
  • GNPX $3.97
  • OLB $3.27
  • Technical
  • Relative Strength Index (RSI)
  • GNPX 69.58
  • OLB 50.32
  • Support Level
  • GNPX $0.20
  • OLB $1.00
  • Resistance Level
  • GNPX $0.40
  • OLB $1.38
  • Average True Range (ATR)
  • GNPX 0.04
  • OLB 0.12
  • MACD
  • GNPX 0.02
  • OLB 0.04
  • Stochastic Oscillator
  • GNPX 61.56
  • OLB 70.00

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About OLB The OLB Group Inc.

The OLB Group Inc is a diversified fintech e-commerce merchant services provider and Bitcoin crypto mining enterprise. It focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. Along with its subsidiaries, the company offers a cloud-based business management platform that provides turnkey solutions for merchants to enable them to build and manage their retail businesses, whether online or at a brick-and-mortar location, payment processing solutions, payment gateway, virtual terminal with proprietary business management tools, and crowdfunding solutions. The company has two business segments; Fintech Services which generates key revenue, and the Bitcoin Mining business segment.

Share on Social Networks: